- Home
- IVVD vs NGS Comparison
IVVD vs NGS Comparison
Compare IVVD & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- NGS
- Stock Information
- Founded
- IVVD 2020
- NGS 1998
- Country
- IVVD United States
- NGS United States
- Employees
- IVVD N/A
- NGS N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- NGS Oilfield Services/Equipment
- Sector
- IVVD Health Care
- NGS Energy
- Exchange
- IVVD Nasdaq
- NGS Nasdaq
- Market Cap
- IVVD 351.6M
- NGS 328.4M
- IPO Year
- IVVD 2021
- NGS 2002
- Fundamental
- Price
- IVVD $1.61
- NGS $28.05
- Analyst Decision
- IVVD Strong Buy
- NGS Strong Buy
- Analyst Count
- IVVD 5
- NGS 3
- Target Price
- IVVD $6.11
- NGS $33.67
- AVG Volume (30 Days)
- IVVD 6.2M
- NGS 43.8K
- Earning Date
- IVVD 11-07-2025
- NGS 11-10-2025
- Dividend Yield
- IVVD N/A
- NGS 1.43%
- EPS Growth
- IVVD N/A
- NGS 33.85
- EPS
- IVVD N/A
- NGS 1.42
- Revenue
- IVVD $46,210,000.00
- NGS $164,109,000.00
- Revenue This Year
- IVVD $102.11
- NGS $9.86
- Revenue Next Year
- IVVD $151.51
- NGS $14.21
- P/E Ratio
- IVVD N/A
- NGS $19.74
- Revenue Growth
- IVVD 1941.08
- NGS 14.77
- 52 Week Low
- IVVD $0.35
- NGS $16.73
- 52 Week High
- IVVD $2.74
- NGS $29.74
- Technical
- Relative Strength Index (RSI)
- IVVD 46.79
- NGS 58.54
- Support Level
- IVVD $1.74
- NGS $27.05
- Resistance Level
- IVVD $2.00
- NGS $28.09
- Average True Range (ATR)
- IVVD 0.24
- NGS 0.83
- MACD
- IVVD -0.06
- NGS 0.09
- Stochastic Oscillator
- IVVD 1.33
- NGS 80.41
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.